Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.51 |
| ▸ | NPY1R | P25929 | 10/20 | 0.51 |
| ▸ | NPY2R | P49146 | 7/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | IL1RN | P18510 | 1/20 | 0.45 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.45 |
| ▸ | GHSR | Q92847 | 1/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2193857 | 0.96 | NPY4R (0.49) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL2184229 | 0.93 | NPY4R (0.60) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL2195052 | 0.85 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL30575177 | 0.83 | NPY1R (0.56) | NPY4RNPY1RNPY2RERAP2GHSR | |
| SCHEMBL27584132 | 0.81 | GHSR (0.53) | OPRK1GHSR | |
| SCHEMBL27584126 | 0.81 | GHSR (0.53) | OPRK1GHSR | |
| SCHEMBL24473464 | 0.81 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RNTSR2 | |
| SCHEMBL24473382 | 0.81 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RNTSR2 | |
| SCHEMBL24473513 | 0.81 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RNTSR2 | |
| SCHEMBL24473470 | 0.81 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RNTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9173951-B2 | Carbohydrate-based drug delivery polymers and conjugates thereof | NEKTAR THERAPEUTICS (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150051371-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | NEKTAR THERAPEUTICS (US) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051371-A1 | CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF | STT3B, STT3A, DDOST | NPY4R 2480/4885NPY1R 3329/4885NPY2R 3255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.